Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001596771-20-000104
Filing Date
2020-11-09
Accepted
2020-11-09 15:37:09
Documents
2
Period of Report
2020-11-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1547
2 poabenton.txt EX-24 2911
  Complete submission text file 0001596771-20-000104.txt   5907
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3916 VALRICO GROVE DRIVE VALRICO FL 33594
Business Address
Benton Susan (Reporting) CIK: 0001373649 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 201297383